James Oliviero
Net worth: 3 M $ as of 2026-07-30
Net worth: 3 M $ as of 2026-07-30
James F.
Oliviero is an Independent Director at Nuvectis Pharma, Inc. since 2021.
Formerly, Mr. Oliviero was President, Chief Executive Officer & Director at Checkpoint Therapeutics, Inc. from 2018 to 2025.
Mr. Oliviero was Finance Director at ACCESS Oncology, Inc. from 1999 to 2003.
Mr. Oliviero was Chief Financial Officer & Treasurer at Keryx Biopharmaceuticals, Inc. in 2015.
Mr. Oliviero completed undergraduate studies at Goizueta Business School-Emory.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-10 | 122,828 ( 0.39% ) | 3 M $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| NUVECTIS PHARMA, INC. | Director/Board Member | 2021-06-30 |
| Companies | Position | End |
|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Chief Executive Officer | 2025-05-29 |
| KERYX BIOPHARMACEUTICALS | Director of Finance/CFO | 2015-08-31 |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Director of Finance/CFO | 2003-04-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Goizueta Business School-Emory
Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkpoint Therapeutics, Inc.
Checkpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions